Advertisement

WhiteOak Capital Pharma and Healthcare Fund Direct Growth INF03VN01886

Morningstar’s Analysis

There is no growth data available.

Returns



Asset Allocation

Asset Class Investment Category Index
Equity 92.88 98.41 100.00
Fixed Income 0.00 0.00 0.00
Preferred 0.00 0.09 0.00
Convertible 0.00 0.00 0.00
Cash 7.12 1.73 0.00
Other 0.00 0.00 0.00

Stock Style

People

Morningstar Risk & Return

Risk vs. Category
Return vs. Category

Holdings

Portfolio Holdings
# Long
# Short
Equity Holding
43 0
Bond Holding
0 0
Other Holding
8 0
Total Holding
51 0
Equity Holdings
43
Bond Holdings
0
Other Holdings
8
Total Holdings
51
% Assets in Top 10 Holdings
53
Reported Turnover %
73.27
As of 03 / 31 / 24
Active Share
50.93
Women Directors %
21
Women Executives %
16
Holdings
% Portfolio Weight
First Bought
Market Value as of Mar 31, 2025
Cur Currency
Share Change %
1-Year Return
Forward P/E
Equity Star Rating
Economic Moat
ESG Risk Rating Assessment
Sector
11.30 Jan 31, 2024 343,002,000
INR Indian Rupee
14.92 Healthcare
7.39 Jan 31, 2024 224,441,000
INR Indian Rupee
9.70 Healthcare
6.08 Apr 30, 2024 184,676,000
INR Indian Rupee
50.63 Healthcare
5.58 May 31, 2024 169,297,000
INR Indian Rupee
20.79 Healthcare
5.14 Apr 30, 2024 155,963,000
INR Indian Rupee
31.85 Healthcare
3.91 Jan 31, 2024 118,850,000
INR Indian Rupee
28.26 Healthcare
3.85 Jan 31, 2024 116,826,000
INR Indian Rupee
65.41 Healthcare
3.81 Jul 31, 2024 115,714,000
INR Indian Rupee
47.48 Healthcare
3.54 Oct 31, 2024 107,616,000
INR Indian Rupee
41.72 Healthcare
2.72 Jan 31, 2024 82,631,000
INR Indian Rupee
56.99 Healthcare
Holdings as of Mar 31, 2025 | The top 51 largest holdings are available for display across Equity, Bond and Other.


© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top